Conditions: Osteoporosis
Keywords: Postmenopausal Osteoporosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 7808
Healthy volunteers: no

Brief summary:
This study will evaluate the effectiveness and safety of denosumab in treating women with Postmenopausal Osteoporosis.

Detailed description:

Arms:
arm 1: Placebo administered subcutaneously once every 6 months for 3 years. arm 2: Denosumab 60 mg administered subcutaneously once every 6 months (Q6M) for 3 years.

Interventions: intervention 1: placebo intervention 2: Denosumab
Intervention descriptions: intervention 1: Placebo administered by subcutaneous injection intervention 2: Denosumab 60 mg administered by subcutaneous injection

Protocol document: